gene,uniprotac,variant,drug,smile,label,source,patho
SLCO1B3,F5H094,S112P,mycophenolic acid,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)O)O,1,pharmgkb,Benign
SLCO1B3,F5H094,S112P,sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,1,pharmgkb,Benign
TBXT,O15178,G177D,flunisolide,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@]35C)F)O,1,pharmgkb,Benign
SLC22A1,O15245,M408V,metformin,CN(C)C(=N)N=C(N)N,1,pharmgkb,Benign
ABCC4,O15439,G187W,latanoprost,CC(C)OC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O,1,pharmgkb,Benign
XRCC3,O43542,T241M,Platinum compounds,[Pt],1,pharmgkb,Pathogenic
SLC28A2,O43868,P22L,gemcitabine,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,1,pharmgkb,Benign
SF3B1,O75533,K666N,Spliceostatin A,C[C@H]1C[C@H]([C@H](O[C@H]1C/C=C(\C)/C=C/[C@@H]2[C@H]([C@@]3(C[C@@](O2)(C)OC)CO3)O)C)NC(=O)/C=C\[C@H](C)OC(=O)C,1,civic,Pathogenic
SF3B1,O75533,K700E,Spliceostatin A,C[C@H]1C[C@H]([C@H](O[C@H]1C/C=C(\C)/C=C/[C@@H]2[C@H]([C@@]3(C[C@@](O2)(C)OC)CO3)O)C)NC(=O)/C=C\[C@H](C)OC(=O)C,1,civic,Pathogenic
IDH1,O75874,R132C,AGI-5198,CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C,1,civic,Pathogenic
IDH1,O75874,R132C,BPTES,C1=CC=C(C=C1)CC(=O)NC2=NN=C(S2)CCSCCC3=NN=C(S3)NC(=O)CC4=CC=CC=C4,1,civic,Pathogenic
IDH1,O75874,R132C,GSK321,C[C@@H]1CN(CC2=C1N(N=C2C(=O)NC3=CC=CC(=C3)[C@H](C)O)CC4=CC=C(C=C4)F)C(=O)C5=CC=CN5,1,civic,Pathogenic
IDH1,O75874,R132C,Ivosidenib,C1CC(=O)N([C@@H]1C(=O)N(C2=CC(=CN=C2)F)[C@@H](C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,1,civic,Pathogenic
IDH1,O75874,R132C,Olaparib,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,1,civic,Pathogenic
IDH1,O75874,R132C,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,1,civic,Pathogenic
IDH1,O75874,R132H,AGI-5198,CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C,1,civic,Pathogenic
ABCA1,O95477,K1587R,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,1,pharmgkb,Benign
ABCA1,O95477,R219K,atorvastatin,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,1,pharmgkb,Benign
ABCA1,O95477,R219K,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,1,pharmgkb,Benign
ABCA1,O95477,R219K,pravastatin,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,1,pharmgkb,Benign
ABCA1,O95477,R219K,rosuvastatin,CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,1,pharmgkb,Benign
ABCA1,O95477,R219K,simvastatin,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,1,pharmgkb,Benign
ADH1B,P00325,R370C,naltrexone,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,1,pharmgkb,Benign
ADH1C,P00326,I350V,naltrexone,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,1,pharmgkb,Benign
F13A1,P00488,V35L,aspirin,CC(=O)OC1=CC=CC=C1C(=O)O,1,pharmgkb,Benign
ABL1,P00519,E255K,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,0,civic,Likely pathogenic
ABL1,P00519,E255K,Bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,0,civic,Likely pathogenic
ABL1,P00519,E255K,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,0,civic,Likely pathogenic
ABL1,P00519,E255K,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Likely pathogenic
ABL1,P00519,E255K,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Likely pathogenic
ABL1,P00519,E255K,Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Likely pathogenic
ABL1,P00519,E255V,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,0,civic,Pathogenic
ABL1,P00519,E255V,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Pathogenic
ABL1,P00519,E255V,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Pathogenic
ABL1,P00519,E255V,Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Pathogenic
ABL1,P00519,E355G,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Likely pathogenic
ABL1,P00519,E355G,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Likely pathogenic
ABL1,P00519,F317C,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,0,civic,Likely pathogenic
ABL1,P00519,F317I,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,0,civic,Likely pathogenic
ABL1,P00519,F317L,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,0,civic,Likely pathogenic
ABL1,P00519,F317L,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,0,civic,Likely pathogenic
ABL1,P00519,F317L,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Likely pathogenic
ABL1,P00519,F317L,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Likely pathogenic
ABL1,P00519,F317L,Ponatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,1,civic,Likely pathogenic
ABL1,P00519,F317V,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,0,civic,Likely pathogenic
ABL1,P00519,F317V,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,0,civic,Likely pathogenic
ABL1,P00519,F359C,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Likely pathogenic
ABL1,P00519,F359I,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Likely pathogenic
ABL1,P00519,F359V,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,0,civic,Likely pathogenic
ABL1,P00519,F359V,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Likely pathogenic
ABL1,P00519,F359V,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Likely pathogenic
ABL1,P00519,F359V,Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Likely pathogenic
ABL1,P00519,G250E,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,0,civic,Likely pathogenic
ABL1,P00519,G250E,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,1,civic,Likely pathogenic
ABL1,P00519,G250E,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Likely pathogenic
ABL1,P00519,G250E,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Likely pathogenic
ABL1,P00519,G250E,Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Likely pathogenic
ABL1,P00519,H396R,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,0,civic,Pathogenic
ABL1,P00519,H396R,Bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,0,civic,Pathogenic
ABL1,P00519,H396R,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Pathogenic
ABL1,P00519,H396R,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Pathogenic
ABL1,P00519,L248V,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,0,civic,Likely pathogenic
ABL1,P00519,L248V,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Likely pathogenic
ABL1,P00519,L248V,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Likely pathogenic
ABL1,P00519,M351T,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Pathogenic
ABL1,P00519,M351T,Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1,civic,Pathogenic
ABL1,P00519,Q252H,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,0,civic,Likely pathogenic
ABL1,P00519,Q252H,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,0,civic,Likely pathogenic
ABL1,P00519,Q252H,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Likely pathogenic
ABL1,P00519,T315A,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,1,civic,Likely pathogenic
ABL1,P00519,T315A,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,0,civic,Likely pathogenic
ABL1,P00519,T315I,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,1,civic,Pathogenic
ABL1,P00519,T315I,Bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,0,civic,Pathogenic
ABL1,P00519,T315I,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,0,civic,Pathogenic
ABL1,P00519,T315I,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Pathogenic
ABL1,P00519,T315I,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Pathogenic
ABL1,P00519,T315I,Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Pathogenic
ABL1,P00519,T315I,Ponatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,1,civic,Pathogenic
ABL1,P00519,V299L,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,1,civic,Likely pathogenic
ABL1,P00519,V299L,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,0,civic,Likely pathogenic
ABL1,P00519,V299L,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Likely pathogenic
ABL1,P00519,V299L,Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1,civic,Likely pathogenic
ABL1,P00519,Y253F,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,0,civic,Likely pathogenic
ABL1,P00519,Y253F,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Likely pathogenic
ABL1,P00519,Y253H,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Pathogenic
EGFR,P00533,A289V,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,1,civic,Likely pathogenic
EGFR,P00533,G598V,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,1,civic,Likely pathogenic
EGFR,P00533,G719A,Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,1,civic,Pathogenic
EGFR,P00533,G719S,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,1,civic,Pathogenic
EGFR,P00533,G719S,Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,1,civic,Pathogenic
EGFR,P00533,L858R,Afatinib,CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,1,civic,Pathogenic
EGFR,P00533,L858R,Canertinib,C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,1,civic,Pathogenic
EGFR,P00533,L858R,Crizotinib,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,0,civic,Pathogenic
EGFR,P00533,L858R,Dacomitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4CCCCC4,1,civic,Pathogenic
EGFR,P00533,L858R,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,1,civic,Pathogenic
EGFR,P00533,L858R,gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,1,pharmgkb,Pathogenic
EGFR,P00533,L858R,Lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,1,civic,Pathogenic
EGFR,P00533,L858R,Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C,1,civic,Pathogenic
EGFR,P00533,L858R,Osimertinib,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,1,civic,Pathogenic
EGFR,P00533,L861Q,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,1,civic,Pathogenic
EGFR,P00533,L861Q,Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,1,civic,Pathogenic
EGFR,P00533,L861R,Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,1,civic,Pathogenic
EGFR,P00533,R108K,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,1,civic,Likely pathogenic
EGFR,P00533,R776C,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,1,civic,Likely pathogenic
EGFR,P00533,R831H,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,1,civic,Pathogenic
EGFR,P00533,S768I,Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,1,civic,Pathogenic
EGFR,P00533,T263P,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,1,civic,Likely pathogenic
EGFR,P00533,T790M,Canertinib,C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,1,civic,Pathogenic
EGFR,P00533,T790M,Lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,0,civic,Pathogenic
EGFR,P00533,T790M,Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C,1,civic,Pathogenic
EGFR,P00533,T790M,Osimertinib,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,1,civic,Pathogenic
EGFR,P00533,T790M,Rociletinib,CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC,1,civic,Pathogenic
EGFR,P00533,T790M,Staurosporine,C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC,1,civic,Pathogenic
EGFR,P00533,V742A,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,1,civic,Likely pathogenic
NRAS,P01111,G13D,Tanespimycin,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,1,civic,Pathogenic
NRAS,P01111,Q61L,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,1,civic,Pathogenic
NRAS,P01111,Q61R,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,1,civic,Pathogenic
HRAS,P01112,G13D,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,0,civic,Pathogenic
KRAS,P01116,A146V,Abemaciclib,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,1,civic,Pathogenic
KRAS,P01116,G12A,Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,0,civic,Pathogenic
KRAS,P01116,G12A,Melphalan,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl,0,civic,Pathogenic
KRAS,P01116,G12A,Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,0,civic,Pathogenic
KRAS,P01116,G12C,Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,0,civic,Pathogenic
KRAS,P01116,G12C,Melphalan,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl,0,civic,Pathogenic
KRAS,P01116,G12C,Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,0,civic,Pathogenic
KRAS,P01116,G12D,Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,0,civic,Pathogenic
KRAS,P01116,G12D,Melphalan,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl,0,civic,Pathogenic
KRAS,P01116,G12D,MK2206,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N.Cl.Cl,1,civic,Pathogenic
KRAS,P01116,G12D,Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,0,civic,Pathogenic
KRAS,P01116,G12D,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,0,civic,Pathogenic
KRAS,P01116,G12R,Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,0,civic,Pathogenic
KRAS,P01116,G12S,Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,0,civic,Pathogenic
KRAS,P01116,G12S,Melphalan,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl,0,civic,Pathogenic
KRAS,P01116,G12S,Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,0,civic,Pathogenic
KRAS,P01116,G12V,Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,0,civic,Pathogenic
KRAS,P01116,G12V,Palbociclib,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,1,civic,Pathogenic
KRAS,P01116,G12V,Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,0,civic,Pathogenic
KRAS,P01116,G13D,Pictilisib,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,0,civic,Pathogenic
KRAS,P01116,G13D,Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,0,civic,Pathogenic
APOE,P02649,C130R,simvastatin,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,1,pharmgkb,Pathogenic
APOE,P02649,C130R,warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,1,pharmgkb,Pathogenic
APOE,P02649,R176C,atorvastatin,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,1,pharmgkb,Pathogenic
APOE,P02649,R176C,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,1,pharmgkb,Pathogenic
APOE,P02649,R176C,fluvastatin,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,1,pharmgkb,Pathogenic
APOE,P02649,R176C,pravastatin,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,1,pharmgkb,Pathogenic
APOE,P02649,R176C,warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,1,pharmgkb,Pathogenic
GC,P02774,D432E,deferasirox,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O,1,pharmgkb,Benign
APOB,P04114,P2739Q,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,1,pharmgkb,Pathogenic
APOB,P04114,R3638Q,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,1,pharmgkb,Benign
APOB,P04114,T98I,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,1,pharmgkb,Benign
SOD2,P04179,V16A,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,1,pharmgkb,Benign
ERBB2,P04626,D769Y,Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C,1,civic,Pathogenic
ERBB2,P04626,G309A,Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C,1,civic,Pathogenic
ERBB2,P04626,L755S,Lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,0,civic,Likely pathogenic
ERBB2,P04626,L755S,Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C,1,civic,Likely pathogenic
ERBB2,P04626,L755W,Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C,1,civic,Likely pathogenic
ERBB2,P04626,N857S,Lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,1,civic,Pathogenic
ERBB2,P04626,R896C,Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C,1,civic,Pathogenic
ERBB2,P04626,V777L,Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C,1,civic,Pathogenic
ERBB2,P04626,V842I,Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C,1,civic,Pathogenic
TP53,P04637,G245S,AMGMDS3,CC[C@@H](C(=O)OCC)N1[C@@H]([C@H]([C@](CC1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC(=CC=C3)Cl,0,civic,Pathogenic
TP53,P04637,M237I,AMGMDS3,CC[C@@H](C(=O)OCC)N1[C@@H]([C@H]([C@](CC1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC(=CC=C3)Cl,0,civic,Pathogenic
TP53,P04637,P47S,Cisplatin,N.N.Cl[Pt]Cl,0,civic,Benign
TP53,P04637,R158H,AMGMDS3,CC[C@@H](C(=O)OCC)N1[C@@H]([C@H]([C@](CC1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC(=CC=C3)Cl,0,civic,Pathogenic
TP53,P04637,R158L,AMGMDS3,CC[C@@H](C(=O)OCC)N1[C@@H]([C@H]([C@](CC1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC(=CC=C3)Cl,0,civic,Pathogenic
TP53,P04637,R175H,AMGMDS3,CC[C@@H](C(=O)OCC)N1[C@@H]([C@H]([C@](CC1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC(=CC=C3)Cl,0,civic,Pathogenic
TP53,P04637,R175H,Doxorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,1,civic,Pathogenic
TP53,P04637,R248Q,AMGMDS3,CC[C@@H](C(=O)OCC)N1[C@@H]([C@H]([C@](CC1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC(=CC=C3)Cl,0,civic,Pathogenic
TP53,P04637,R248W,AMGMDS3,CC[C@@H](C(=O)OCC)N1[C@@H]([C@H]([C@](CC1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC(=CC=C3)Cl,0,civic,Pathogenic
TP53,P04637,R273C,AMGMDS3,CC[C@@H](C(=O)OCC)N1[C@@H]([C@H]([C@](CC1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC(=CC=C3)Cl,0,civic,Pathogenic
TP53,P04637,R273H,AMGMDS3,CC[C@@H](C(=O)OCC)N1[C@@H]([C@H]([C@](CC1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC(=CC=C3)Cl,0,civic,Pathogenic
TP53,P04637,V157F,AMGMDS3,CC[C@@H](C(=O)OCC)N1[C@@H]([C@H]([C@](CC1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC(=CC=C3)Cl,0,civic,Pathogenic
TP53,P04637,Y220C,AMGMDS3,CC[C@@H](C(=O)OCC)N1[C@@H]([C@H]([C@](CC1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC(=CC=C3)Cl,0,civic,Pathogenic
ITGB3,P05106,L59P,clopidogrel,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,1,pharmgkb,Benign
CYP2E1,P05181,F421L,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,1,pharmgkb,Benign
BCHE,P06276,A567T,donepezil,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,1,pharmgkb,Pathogenic
BCHE,P06276,A567T,rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,1,pharmgkb,Pathogenic
GLA,P06280,A156T,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,D264N,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,D313Y,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,D322E,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,D33G,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,G183D,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,G373S,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,G85A,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,I253T,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Likely pathogenic
GLA,P06280,L300P,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,L36W,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,M187I,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,P205T,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,P259L,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,R112H,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,R301L,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,R356W,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GLA,P06280,Y216C,migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,1,pharmgkb,Pathogenic
GP1BA,P07359,T161M,aspirin,CC(=O)OC1=CC=CC=C1C(=O)O,1,pharmgkb,Benign
RET,P07949,C634W,Motesanib,CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C,0,civic,Pathogenic
RET,P07949,M918T,AZD1480,CC1=CC(=NN1)NC2=NC(=NC=C2Cl)N[C@@H](C)C3=NC=C(C=N3)F,1,civic,Pathogenic
RET,P07949,M918T,Cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,1,civic,Pathogenic
RET,P07949,M918T,Motesanib,CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C,0,civic,Pathogenic
RET,P07949,M918T,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,1,civic,Pathogenic
ABCB1,P08183,I1145M,agomelatine,CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC,1,pharmgkb,Benign
ABCB1,P08183,I1145M,atorvastatin,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,1,pharmgkb,Benign
ABCB1,P08183,I1145M,cytarabine,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,1,pharmgkb,Benign
ABCB1,P08183,I1145M,granisetron,CN1[C@@H]2CCC[C@H]1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,1,pharmgkb,Benign
ABCB1,P08183,I1145M,imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1,pharmgkb,Benign
ABCB1,P08183,I1145M,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,1,pharmgkb,Benign
ABCB1,P08183,I1145M,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,1,pharmgkb,Benign
ABCB1,P08183,I1145M,morphine,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,1,pharmgkb,Benign
ABCB1,P08183,I1145M,ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,1,pharmgkb,Benign
ABCB1,P08183,I1145M,oxaliplatin,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],1,pharmgkb,Benign
ABCB1,P08183,I1145M,phenobarbital,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,1,pharmgkb,Benign
ABCB1,P08183,I1145M,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,1,pharmgkb,Benign
ABCB1,P08183,I1145M,Platinum compounds,[Pt],1,pharmgkb,Benign
ABCB1,P08183,I1145M,remifentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,1,pharmgkb,Benign
ABCB1,P08183,I1145M,tacrolimus,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,1,pharmgkb,Benign
ABCB1,P08183,I1145M,tamoxifen,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,1,pharmgkb,Benign
ABCB1,P08183,I1145M,tramadol,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,1,pharmgkb,Benign
ABCB1,P08183,I1145M,venlafaxine,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,1,pharmgkb,Benign
ABCB1,P08183,I1145M,vincristine,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,1,pharmgkb,Benign
ABCB1,P08183,S400N,tacrolimus,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,1,pharmgkb,Benign
ABCB1,P08183,S400N,temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,1,pharmgkb,Benign
ABCB1,P08183,S893A,atorvastatin,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,1,pharmgkb,Benign
ABCB1,P08183,S893A,cyclosporine,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,1,pharmgkb,Benign
ABCB1,P08183,S893A,fluoxetine,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,1,pharmgkb,Benign
ABCB1,P08183,S893A,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,1,pharmgkb,Benign
ABCB1,P08183,S893A,ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,1,pharmgkb,Benign
ABCB1,P08183,S893A,paclitaxel,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,1,pharmgkb,Benign
ABCB1,P08183,S893A,pravastatin,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,1,pharmgkb,Benign
ABCB1,P08183,S893A,simvastatin,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,1,pharmgkb,Benign
ABCB1,P08183,S893A,sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,1,pharmgkb,Benign
ABCB1,P08183,S893A,tacrolimus,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,1,pharmgkb,Benign
ABCB1,P08183,S893A,tramadol,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,1,pharmgkb,Benign
ABCB1,P08183,S893T,Paclitaxel,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,1,civic,Benign
NR3C2,P08235,V180I,enalapril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,1,pharmgkb,Benign
MET,P08581,D1228N,Crizotinib,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,0,civic,Pathogenic
ADRB1,P08588,S49G,carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,1,pharmgkb,Benign
ADRB1,P08588,S49G,metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,1,pharmgkb,Benign
ADRB1,P08588,S49G,timolol,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O,1,pharmgkb,Benign
CYP3A4,P08684,M445T,fluvastatin,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,1,pharmgkb,Benign
ADRA2A,P08913,N266K,dexmedetomidine,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C,1,pharmgkb,Benign
ROS1,P08922,G2032R,Cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,1,civic,Pathogenic
ROS1,P08922,G2032R,Foretinib,COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,1,civic,Pathogenic
ROS1,P08922,G2032R,Lorlatinib,C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,1,civic,Pathogenic
GSTP1,P09211,A114V,cisplatin,N.N.Cl[Pt]Cl,1,pharmgkb,Benign
GSTP1,P09211,I105V,cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,1,pharmgkb,Benign
GSTP1,P09211,I105V,dimethyl fumarate,COC(=O)/C=C/C(=O)OC,1,pharmgkb,Benign
GSTP1,P09211,I105V,FOLFOX Regimen,[CH2-][C@@H]1CCCC[C@H]1[CH2-].C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O.C1=C(C(=O)NC(=O)N1)F.C(=O)(C(=O)O)O.[Pt+2],1,civic,Benign
GSTP1,P09211,I105V,Platinum compounds,[Pt],1,pharmgkb,Benign
ARAF,P10398,S214C,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,1,civic,Likely pathogenic
ARAF,P10398,S214C,Trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,1,civic,Likely pathogenic
CYP2D6,P10635,P34A,escitalopram,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,1,pharmgkb,Likely benign
KIT,P10721,D816H,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Pathogenic
KIT,P10721,D816V,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Pathogenic
KIT,P10721,D816V,Midostaurin,C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,1,civic,Pathogenic
KIT,P10721,D820A,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Pathogenic
KIT,P10721,D820G,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Pathogenic
KIT,P10721,D820Y,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Pathogenic
KIT,P10721,D820Y,Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,1,civic,Pathogenic
KIT,P10721,D820Y,Sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,1,civic,Pathogenic
KIT,P10721,K642E,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,1,civic,Pathogenic
KIT,P10721,K642E,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1,civic,Pathogenic
KIT,P10721,L576P,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,1,civic,Pathogenic
KIT,P10721,L576P,Sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,0,civic,Pathogenic
KIT,P10721,M541L,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1,civic,Pathogenic
KIT,P10721,N822K,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Pathogenic
KIT,P10721,N822K,Ponatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,1,civic,Pathogenic
KIT,P10721,V559D,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1,civic,Pathogenic
KIT,P10721,V560D,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,1,civic,Pathogenic
KIT,P10721,V560D,Sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,0,civic,Pathogenic
KIT,P10721,V654A,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Pathogenic
KIT,P10721,V654A,Sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,1,civic,Pathogenic
KIT,P10721,Y823D,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Likely pathogenic
FGFR1,P11362,N546K,Pemigatinib,CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5,1,civic,Pathogenic
FGFR1,P11362,N546K,Ponatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,1,civic,Pathogenic
MTHFD1,P11586,R653Q,methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,1,pharmgkb,Benign
CETP,P11597,V422I,fluvastatin,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,1,pharmgkb,Benign
CETP,P11597,V422I,rosuvastatin,CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,1,pharmgkb,Benign
CETP,P11597,V422I,simvastatin,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,1,pharmgkb,Benign
CYP2C9,P11712,I359L,losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,1,pharmgkb,Benign
CYP2C9,P11712,R144C,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,1,pharmgkb,Benign
CDK4,P11802,R24C,Palbociclib,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,1,civic,Pathogenic
CFTR,P13569,A1067P,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Likely pathogenic
CFTR,P13569,A455E,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,A561E,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,A561E,lumacaftor,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,1,pharmgkb,Pathogenic
CFTR,P13569,D110E,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,D110H,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,D1152H,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,D1270N,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,D579A,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,E56K,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,E92K,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,F1052L,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,F1074L,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Likely pathogenic
CFTR,P13569,G1244V,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,G1249R,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,G1349D,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,G178R,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,G551D,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,G551S,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,G970R,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,H1054D,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,I336K,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,L206W,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,L927P,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,L997F,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,M1V,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,P67L,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,R1066L,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,R1070Q,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,R1070W,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,R117G,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,R117H,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,R334W,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,R347L,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,R352Q,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,R668C,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,R74W,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,S1235R,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,S1251N,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,S1255P,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,S549N,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,S549R,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,S549R,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,S945L,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,S977F,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
CFTR,P13569,T338I,ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,1,pharmgkb,Pathogenic
BRAF,P15056,D594G,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,1,civic,Pathogenic
BRAF,P15056,D594G,Trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,1,civic,Pathogenic
BRAF,P15056,D594G,U0126,C1=CC=C(C(=C1)N)S/C(=C(/C(=C(/SC2=CC=CC=C2N)\N)/C#N)\C#N)/N,0,civic,Pathogenic
BRAF,P15056,G469E,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,1,civic,Pathogenic
BRAF,P15056,G469E,U0126,C1=CC=C(C(=C1)N)S/C(=C(/C(=C(/SC2=CC=CC=C2N)\N)/C#N)\C#N)/N,0,civic,Pathogenic
BRAF,P15056,L597Q,Trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,1,civic,Pathogenic
BRAF,P15056,L597R,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,1,civic,Pathogenic
BRAF,P15056,L597S,MEK Inhibitor TAK-733,CN1C2=C(C(=C(C1=O)F)NC3=C(C=C(C=C3)I)F)C(=O)N(C=N2)C[C@H](CO)O,1,civic,Pathogenic
BRAF,P15056,L597V,Trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,1,civic,Pathogenic
BRAF,P15056,V600D,BRAF Inhibitor,CC(C)S(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CN=CC=C4)F,1,civic,Pathogenic
BRAF,P15056,V600D,Dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,1,civic,Pathogenic
BRAF,P15056,V600D,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,1,civic,Pathogenic
BRAF,P15056,V600E,Cobimetinib,C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,1,civic,Likely pathogenic
BRAF,P15056,V600E,Dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,0,civic,Likely pathogenic
BRAF,P15056,V600E,Irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,0,civic,Likely pathogenic
BRAF,P15056,V600E,Oxaliplatin,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],0,civic,Likely pathogenic
BRAF,P15056,V600E,Pictilisib,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,1,civic,Likely pathogenic
BRAF,P15056,V600E,Trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,1,civic,Likely pathogenic
BRAF,P15056,V600K,Dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,1,civic,Pathogenic
BRAF,P15056,V600K,Trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,1,civic,Pathogenic
BRAF,P15056,V600K,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,1,civic,Pathogenic
NQO1,P15559,P187S,Amrubicin,CC(=O)[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O)O[C@H]5C[C@@H]([C@@H](CO5)O)O)N,1,civic,Pathogenic
NQO1,P15559,P187S,Platinum compounds,[Pt],1,pharmgkb,Pathogenic
NQO1,P15559,P187S,warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,1,pharmgkb,Pathogenic
PDGFRA,P16234,D842I,Crenolanib,CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,1,civic,Likely pathogenic
PDGFRA,P16234,D842V,Crenolanib,CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,1,civic,Pathogenic
PDGFRA,P16234,D842V,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Pathogenic
PDGFRA,P16234,D842V,Imatinib Mesylate,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,0,civic,Pathogenic
PDGFRA,P16234,D842V,Sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,0,civic,Pathogenic
PDGFRA,P16234,D842Y,Crenolanib,CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,1,civic,Likely pathogenic
PDGFRA,P16234,T674I,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,0,civic,Pathogenic
PDGFRA,P16234,T674I,Ponatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,1,civic,Pathogenic
PDGFRA,P16234,V561A,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1,civic,Pathogenic
PDGFRA,P16234,V561D,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1,civic,Pathogenic
ERCC2,P18074,K751Q,Cisplatin,N.N.Cl[Pt]Cl,0,civic,Benign
XRCC1,P18887,Q399R,fluorouracil,C1=C(C(=O)NC(=O)N1)F,1,pharmgkb,Benign
XRCC1,P18887,Q399R,Platinum compounds,[Pt],1,pharmgkb,Benign
XRCC1,P18887,R194W,Platinum compounds,[Pt],1,pharmgkb,Benign
UGT1A6,P19224,R184S,aspirin,CC(=O)OC1=CC=CC=C1C(=O)O,1,pharmgkb,Benign
UGT1A6,P19224,T181A,aspirin,CC(=O)OC1=CC=CC=C1C(=O)O,1,pharmgkb,Benign
CYP2B6,P20813,K262R,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,1,pharmgkb,Benign
ERBB3,P21860,G284R,Afatinib,CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,1,civic,Likely pathogenic
ERBB3,P21860,R103G,Afatinib,CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,1,civic,Pathogenic
ERBB3,P21860,V104M,Afatinib,CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,1,civic,Pathogenic
COMT,P21964,V158M,clozapine,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42,1,pharmgkb,Benign
COMT,P21964,V158M,entacapone,CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N,1,pharmgkb,Benign
COMT,P21964,V158M,fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,1,pharmgkb,Benign
COMT,P21964,V158M,fluvoxamine,COCCCC/C(=N\OCCN)/C1=CC=C(C=C1)C(F)(F)F,1,pharmgkb,Benign
COMT,P21964,V158M,modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,1,pharmgkb,Benign
COMT,P21964,V158M,morphine,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,1,pharmgkb,Benign
COMT,P21964,V158M,nicotine,CN1CCC[C@H]1C2=CN=CC=C2,1,pharmgkb,Benign
COMT,P21964,V158M,opioids,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3.CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2.CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,1,pharmgkb,Benign
COMT,P21964,V158M,oxycodone,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,1,pharmgkb,Benign
COMT,P21964,V158M,paroxetine,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,1,pharmgkb,Benign
COMT,P21964,V158M,propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,1,pharmgkb,Benign
COMT,P21964,V158M,remifentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,1,pharmgkb,Benign
COMT,P21964,V158M,venlafaxine,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,1,pharmgkb,Benign
FGFR4,P22455,G388R,everolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,1,pharmgkb,Pathogenic
FGFR3,P22607,S249C,Cisplatin,N.N.Cl[Pt]Cl,0,civic,Pathogenic
FGFR3,P22607,S249C,Pazopanib,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,1,civic,Pathogenic
JAK1,P23458,S703I,Ruxolitinib,C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,1,civic,Pathogenic
BDNF,P23560,V66M,olanzapine,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,1,pharmgkb,Benign
BDNF,P23560,V66M,paroxetine,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,1,pharmgkb,Benign
CHAT,P28329,A120T,olanzapine,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,1,pharmgkb,Benign
MAPK1,P28482,E322K,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,1,civic,Pathogenic
ERCC5,P28715,D1104H,platinum,[Pt],1,pharmgkb,Benign
NOS3,P29474,D298E,daunorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,1,pharmgkb,Pathogenic
NOS3,P29474,D298E,salvianolic acid b,C1=CC(=C(C=C1C[C@H](C(=O)O)OC(=O)/C=C/C2=C3[C@@H]([C@H](OC3=C(C=C2)O)C4=CC(=C(C=C4)O)O)C(=O)O[C@H](CC5=CC(=C(C=C5)O)O)C(=O)O)O)O,1,pharmgkb,Pathogenic
NOS3,P29474,D298E,sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,1,pharmgkb,Pathogenic
AKT1,P31749,E17K,Capivasertib,C1CN(CCC1(C(=O)N[C@@H](CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,1,civic,Pathogenic
AKT1,P31749,E17K,Uprosertib,CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)N[C@@H](CC3=CC(=C(C=C3)F)F)CN)Cl,1,civic,Pathogenic
AKT1,P31749,E17K,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,0,civic,Pathogenic
AKT1,P31749,Q79K,Dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,0,civic,Likely pathogenic
AKT1,P31749,Q79K,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,0,civic,Likely pathogenic
ATIC,P31939,T116S,methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,1,pharmgkb,Benign
DRD3,P35462,G9S,clozapine,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42,1,pharmgkb,Benign
DRD3,P35462,G9S,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,1,pharmgkb,Benign
DRD3,P35462,G9S,olanzapine,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,1,pharmgkb,Benign
DRD3,P35462,G9S,paroxetine,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,1,pharmgkb,Benign
DRD3,P35462,G9S,pramipexole,CCCN[C@H]1CCC2=C(C1)SC(=N2)N,1,pharmgkb,Benign
DRD3,P35462,G9S,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,1,pharmgkb,Benign
SCN4A,P35499,I1310N,flecainide,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,1,pharmgkb,Pathogenic
SCN4A,P35499,I1310N,mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,1,pharmgkb,Pathogenic
SCN4A,P35499,N1297K,mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,1,pharmgkb,Pathogenic
SCN4A,P35499,T1313M,flecainide,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,1,pharmgkb,Pathogenic
SCN4A,P35499,T1313M,mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,1,pharmgkb,Pathogenic
FLT4,P35916,R1324L,sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,1,pharmgkb,Benign
FLT4,P35916,T494A,sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,1,pharmgkb,Benign
KDR,P35968,Q472H,sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,1,pharmgkb,Benign
FLT3,P36888,D835H,Gilteritinib,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,1,civic,Pathogenic
FLT3,P36888,D835H,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,0,civic,Pathogenic
FLT3,P36888,D835V,Gilteritinib,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,1,civic,Pathogenic
FLT3,P36888,D835V,Sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,1,civic,Pathogenic
FLT3,P36888,D835V,Tandutinib,CC(C)OC1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCCC5,0,civic,Pathogenic
PPARG,P37231,P12A,pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,1,pharmgkb,Benign
GGCX,P38435,R325Q,warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,1,pharmgkb,Benign
FOLR3,P41439,R98C,pemetrexed,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O,1,pharmgkb,Benign
SLC19A1,P41440,H27R,irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,1,pharmgkb,Benign
SLC19A1,P41440,H27R,methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,1,pharmgkb,Benign
SLC19A1,P41440,H27R,Platinum compounds,[Pt],1,pharmgkb,Benign
PIK3CA,P42336,C420R,BCP32858,CCC1(C2=C(COC1=O)C(=O)N3CC4=C5C(CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)NC(=O)CO)O,0,civic,Pathogenic
PIK3CA,P42336,C420R,Pictilisib,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,1,civic,Pathogenic
PIK3CA,P42336,D350G,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,0,civic,Pathogenic
PIK3CA,P42336,E542K,Apitolisib,CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)[C@H](C)O,1,civic,Pathogenic
PIK3CA,P42336,E542K,MEN1611,CS(=O)(=O)N1CCC2=C(N=C(N=C21)N3CCOCC3)C4=CN=C(N=C4)N,1,civic,Pathogenic
PIK3CA,P42336,E542K,Pictilisib,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,1,civic,Pathogenic
PIK3CA,P42336,E542K,Sirolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,1,civic,Pathogenic
PIK3CA,P42336,E545G,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,0,civic,Pathogenic
PIK3CA,P42336,E545K,Apitolisib,CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)[C@H](C)O,1,civic,Pathogenic
PIK3CA,P42336,E545K,BCP32858,CCC1(C2=C(COC1=O)C(=O)N3CC4=C5C(CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)NC(=O)CO)O,0,civic,Pathogenic
PIK3CA,P42336,E545K,Cisplatin,N.N.Cl[Pt]Cl,0,civic,Pathogenic
PIK3CA,P42336,E545K,Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,0,civic,Pathogenic
PIK3CA,P42336,E545K,Pictilisib,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,1,civic,Pathogenic
PIK3CA,P42336,E545K,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,0,civic,Pathogenic
PIK3CA,P42336,H1047L,PI-103,C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O,1,civic,Pathogenic
PIK3CA,P42336,H1047L,Pictilisib,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,1,civic,Pathogenic
PIK3CA,P42336,H1047R,Alpelisib,CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,1,civic,Pathogenic
PIK3CA,P42336,H1047R,BCP32858,CCC1(C2=C(COC1=O)C(=O)N3CC4=C5C(CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)NC(=O)CO)O,0,civic,Pathogenic
PIK3CA,P42336,H1047R,Dactolisib,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,1,civic,Pathogenic
PIK3CA,P42336,H1047R,MEN1611,CS(=O)(=O)N1CCC2=C(N=C(N=C21)N3CCOCC3)C4=CN=C(N=C4)N,1,civic,Pathogenic
PIK3CA,P42336,H1047R,Pictilisib,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,1,civic,Pathogenic
PIK3CA,P42336,H1047R,Taselisib,CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C,1,civic,Pathogenic
PIK3CA,P42336,H1047R,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,0,civic,Pathogenic
PIK3CA,P42336,K111N,PI-103,C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O,1,civic,Likely pathogenic
PIK3CA,P42336,K111N,Pictilisib,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,1,civic,Likely pathogenic
MTOR,P42345,C1483Y,Sirolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,1,civic,Pathogenic
MTOR,P42345,E1799K,Sirolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,1,civic,Pathogenic
MTOR,P42345,M2327I,AZD8055,C[C@H]1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOC[C@@H]5C,0,civic,Pathogenic
MTOR,P42345,S2215Y,Sirolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,1,civic,Pathogenic
MTHFR,P42898,A222V,benazepril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O,1,pharmgkb,Benign
MTHFR,P42898,A222V,disulfiram,CCN(CC)C(=S)SSC(=S)N(CC)CC,1,pharmgkb,Benign
MTHFR,P42898,A222V,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,1,civic,Benign
MTHFR,P42898,A222V,methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,1,pharmgkb,Benign
MTHFR,P42898,A222V,pemetrexed,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O,1,pharmgkb,Benign
MTHFR,P42898,A222V,pravastatin,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,1,pharmgkb,Benign
MTHFR,P42898,E429A,methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,1,pharmgkb,Benign
CHRNA4,P43681,S543R,varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23,1,pharmgkb,Benign
GNAQ,P50148,Q209P,PLX4720,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)Cl)F,0,civic,Pathogenic
GNAQ,P50148,Q209P,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,0,civic,Pathogenic
BRCA2,P51587,M1I,Rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,1,civic,Pathogenic
BRCA2,P51587,M1R,Rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,1,civic,Pathogenic
BRCA2,P51587,R2336P,Rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,1,civic,Pathogenic
BRCA2,P51587,V159M,Rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,1,civic,Pathogenic
BRCA2,P51587,V211I,Rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,1,civic,Pathogenic
BRCA2,P51587,V211L,Rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,1,civic,Pathogenic
ALDH5A1,P51649,H180Y,methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,1,pharmgkb,Benign
CYP4F2,P78329,V433M,warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,1,pharmgkb,Benign
MC1R,Q01726,V92M,desipramine,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,1,pharmgkb,Benign
MAP2K1,Q02750,C121S,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,0,civic,Pathogenic
MAP2K1,Q02750,K57N,Selumetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,1,civic,Pathogenic
MAP2K1,Q02750,P124S,Selumetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,0,civic,Pathogenic
MAP2K1,Q02750,Q56P,Selumetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,0,civic,Pathogenic
BTK,Q06187,C481S,Ibrutinib,C=CC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,0,civic,Pathogenic
AOX1,Q06278,N1135S,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],1,pharmgkb,Benign
KCNH2,Q12809,N588K,disopyramide,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,1,pharmgkb,Pathogenic
KCNH2,Q12809,N588K,quinidine,COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,1,pharmgkb,Pathogenic
ATM,Q13315,D1682H,Doxorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,0,civic,Pathogenic
ATM,Q13315,R3008C,Doxorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,0,civic,Pathogenic
ATM,Q13315,T2666A,Doxorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,0,civic,Likely pathogenic
NEUROD1,Q13562,T45S,repaglinide,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,1,pharmgkb,Benign
KCNJ11,Q14654,K23Q,gliclazide,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,1,pharmgkb,Benign
KCNJ11,Q14654,K23Q,repaglinide,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,1,pharmgkb,Benign
STK11,Q15831,D194E,Everolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,1,civic,Likely pathogenic
ETFDH,Q16134,T31I,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,1,pharmgkb,Benign
CYP1B1,Q16678,A119S,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,1,pharmgkb,Benign
CYP1B1,Q16678,R48G,risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,1,pharmgkb,Benign
DDR2,Q16832,G253C,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,1,civic,Likely pathogenic
DDR2,Q16832,G505S,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,1,civic,Likely pathogenic
DDR2,Q16832,G774V,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,1,civic,Likely pathogenic
DDR2,Q16832,I638F,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,1,civic,Likely pathogenic
DDR2,Q16832,L239R,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,1,civic,Likely pathogenic
DDR2,Q16832,L63V,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,1,civic,Likely pathogenic
PEAR1,Q5VY43,N848K,prasugrel,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,1,pharmgkb,Benign
APOA5,Q6Q788,S19L,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,1,pharmgkb,Benign
KMT2E,Q8IZD2,G999C,duloxetine,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,1,pharmgkb,Benign
ANKK1,Q8NFD2,E713K,bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,1,pharmgkb,Benign
ANKK1,Q8NFD2,E713K,disulfiram,CCN(CC)C(=S)SSC(=S)N(CC)CC,1,pharmgkb,Benign
ANKK1,Q8NFD2,E713K,nicotine,CN1CCC[C@H]1C2=CN=CC=C2,1,pharmgkb,Benign
ANKK1,Q8NFD2,E713K,prochlorperazine,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,1,pharmgkb,Benign
SCARB1,Q8WTV0,G2S,fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,1,pharmgkb,Benign
MYLIP,Q8WY64,N342I,atorvastatin,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,1,pharmgkb,Benign
ABCC2,Q92887,C1515Y,lopinavir,CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O,1,pharmgkb,Benign
ABCC2,Q92887,V417I,imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1,pharmgkb,Benign
CSF3R,Q99062,T618I,Ruxolitinib,C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,1,civic,Pathogenic
MTR,Q99707,D919G,benazepril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O,1,pharmgkb,Benign
MTR,Q99707,D919G,methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,1,pharmgkb,Benign
SMO,Q99835,D473H,Patidegib,C[C@H]1C[C@@H]2[C@H]([C@H]([C@]3(O2)CC[C@H]4[C@@H]5CC[C@@H]6C[C@@H](CC[C@@]6([C@H]5CC4=C(C3)C)C)NS(=O)(=O)C)C)NC1,1,civic,Pathogenic
SMO,Q99835,D473H,Vismodegib,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,0,civic,Pathogenic
SMO,Q99835,L412F,Vismodegib,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,0,civic,Pathogenic
SLC22A4,Q9H015,L503F,imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,1,pharmgkb,Benign
ABCG8,Q9H221,D19N,atorvastatin,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,1,pharmgkb,Pathogenic
CDH23,Q9H251,V1675I,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,1,pharmgkb,Benign
PIGM,Q9H3S5,F365L,methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,1,pharmgkb,Benign
UGT1A8,Q9HAW9,A173G,raloxifene,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,1,pharmgkb,Benign
GP6,Q9HCN6,P219A,aspirin,CC(=O)OC1=CC=CC=C1C(=O)O,1,pharmgkb,Benign
TLR7,Q9NYK1,Q11P,imiquimod,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,1,pharmgkb,Benign
ALK,Q9UM73,F1174L,Alectinib,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,1,civic,Pathogenic
ALK,Q9UM73,F1174L,AZD3463,COC1=C(C=CC(=C1)N2CCC(CC2)N)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl,1,civic,Pathogenic
ALK,Q9UM73,F1174L,Lorlatinib,C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,1,civic,Pathogenic
ALK,Q9UM73,F1174L,TAE684,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,1,civic,Pathogenic
ALK,Q9UM73,F1245C,Ceritinib,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,1,civic,Pathogenic
ALK,Q9UM73,F1245C,Crizotinib,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,0,civic,Pathogenic
ALK,Q9UM73,F1245C,Lorlatinib,C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,1,civic,Pathogenic
ALK,Q9UM73,F1245V,Entrectinib,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6,1,civic,Pathogenic
ALK,Q9UM73,G1202R,Alectinib,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,0,civic,Likely pathogenic
ALK,Q9UM73,G1202R,Brigatinib,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,0,civic,Likely pathogenic
ALK,Q9UM73,G1202R,Ceritinib,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,0,civic,Likely pathogenic
ALK,Q9UM73,G1202R,Crizotinib,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,0,civic,Likely pathogenic
ALK,Q9UM73,G1202R,Tanespimycin,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,1,civic,Likely pathogenic
ALK,Q9UM73,G1269A,Alectinib,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,0,civic,Likely pathogenic
ALK,Q9UM73,G1269A,Brigatinib,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,1,civic,Likely pathogenic
ALK,Q9UM73,G1269A,Ceritinib,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,1,civic,Likely pathogenic
ALK,Q9UM73,G1269A,Crizotinib,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,0,civic,Likely pathogenic
ALK,Q9UM73,L1152R,Crizotinib,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,0,civic,Likely pathogenic
ALK,Q9UM73,L1196M,Alectinib,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,1,civic,Likely pathogenic
ALK,Q9UM73,L1196M,Ceritinib,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,1,civic,Likely pathogenic
ALK,Q9UM73,L1196M,Crizotinib,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,0,civic,Likely pathogenic
ALK,Q9UM73,R1275Q,Crizotinib,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,1,civic,Pathogenic
ALK,Q9UM73,R1275Q,Lorlatinib,C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,1,civic,Pathogenic
ALK,Q9UM73,S1206Y,Ceritinib,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,1,civic,Likely pathogenic
ALK,Q9UM73,S1206Y,Crizotinib,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,0,civic,Likely pathogenic
ALK,Q9UM73,V1180L,Alectinib,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,0,civic,Likely pathogenic
ALK,Q9UM73,V1180L,Brigatinib,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,1,civic,Likely pathogenic
ALK,Q9UM73,V1180L,Ceritinib,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,1,civic,Likely pathogenic
ALK,Q9UM73,V1180L,Crizotinib,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,0,civic,Likely pathogenic
ALK,Q9UM73,V1180L,TAE684,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,1,civic,Likely pathogenic
GABRQ,Q9UN88,I478L,venlafaxine,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,1,pharmgkb,Benign
ABCG2,Q9UNQ0,Q141K,allopurinol,C1=NNC2=C1C(=O)NC=N2,1,pharmgkb,Benign
ABCG2,Q9UNQ0,Q141K,rosuvastatin,CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,1,pharmgkb,Benign
ABCG2,Q9UNQ0,Q141K,sulfasalazine,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,1,pharmgkb,Benign
SH2B3,Q9UQQ2,W262G,candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,1,pharmgkb,Benign
AKT3,Q9Y243,E17K,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,0,civic,Pathogenic
SLCO1B1,Q9Y6L6,N130D,Methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,1,civic,Benign
SLCO1B1,Q9Y6L6,N130H,atorvastatin,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,1,pharmgkb,Benign
SLCO1B1,Q9Y6L6,N130H,irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,1,pharmgkb,Benign
SLCO1B1,Q9Y6L6,N130H,rocuronium,CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C,1,pharmgkb,Benign
SLCO1B1,Q9Y6L6,P155T,fluvastatin,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,1,pharmgkb,Benign
SLCO1B1,Q9Y6L6,V174A,methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,1,pharmgkb,Pathogenic
SLCO1B1,Q9Y6L6,V174A,pravastatin,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,1,pharmgkb,Pathogenic
SLCO1B1,Q9Y6L6,V174A,repaglinide,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,1,pharmgkb,Pathogenic
SLCO1B1,Q9Y6L6,V174A,rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,1,pharmgkb,Pathogenic
SLCO1B1,Q9Y6L6,V174A,simvastatin,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,1,pharmgkb,Pathogenic
